Dr. Kumar Discusses Advances in the Field of Multiple Myeloma

Shaji K. Kumar, MD
Published: Wednesday, Jun 28, 2017



Shaji K. Kumar, MD, professor of Medicine, Mayo Clinic, discusses advances in the field of multiple myeloma.

The field of multiple myeloma, especially in the newly diagnosed patients, is moving forward, says Kumar.

The first completely oral treatment for newly diagnosed patients with multiple myeloma is ixazomib (Ninlaro), lenalidomide (Revlimid) and dexamethasone, which is under investigation now.
 


Shaji K. Kumar, MD, professor of Medicine, Mayo Clinic, discusses advances in the field of multiple myeloma.

The field of multiple myeloma, especially in the newly diagnosed patients, is moving forward, says Kumar.

The first completely oral treatment for newly diagnosed patients with multiple myeloma is ixazomib (Ninlaro), lenalidomide (Revlimid) and dexamethasone, which is under investigation now.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x